Novel therapeutics demonstrate improved disease modification in systemic sclerosis, indicating new approaches to vascular injury and inflammation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Batani et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: